Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.

Limagne E, Thibaudin M, Nuttin L, Spill A, Derangère V, Fumet JD, Amellal N, Peranzoni E, Cattan V, Ghiringhelli F.

Cancer Immunol Res. 2019 Dec;7(12):1958-1969. doi: 10.1158/2326-6066.CIR-19-0228. Epub 2019 Oct 14.


Blockade of β-Adrenergic Receptors Improves CD8+ T-cell Priming and Cancer Vaccine Efficacy.

Daher C, Vimeux L, Stoeva R, Peranzoni E, Bismuth G, Wieduwild E, Lucas B, Donnadieu E, Bercovici N, Trautmann A, Feuillet V.

Cancer Immunol Res. 2019 Nov;7(11):1849-1863. doi: 10.1158/2326-6066.CIR-18-0833. Epub 2019 Sep 16.


[Improving efficacy of cancer immunotherapy through targeting of macrophages].

Peranzoni E, Donnadieu E.

Med Sci (Paris). 2019 Mar;35(3):207-209. doi: 10.1051/medsci/2019043. Epub 2019 Apr 1. French. No abstract available.


Improving efficacy of cancer immunotherapy through targeting of macrophages.

Peranzoni E, Donnadieu E.

Hum Vaccin Immunother. 2019;15(1):189-192. doi: 10.1080/21645515.2018.1515447. Epub 2018 Sep 7.


Identification of a new subset of lymph node stromal cells involved in regulating plasma cell homeostasis.

Huang HY, Rivas-Caicedo A, Renevey F, Cannelle H, Peranzoni E, Scarpellino L, Hardie DL, Pommier A, Schaeuble K, Favre S, Vogt TK, Arenzana-Seisdedos F, Schneider P, Buckley CD, Donnadieu E, Luther SA.

Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6826-E6835. doi: 10.1073/pnas.1712628115. Epub 2018 Jul 2.


Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.

Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari-Mimoun C, Bercovici N, Guérin M, Biton J, Ouakrim H, Régnier F, Lupo A, Alifano M, Damotte D, Donnadieu E.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4041-E4050. doi: 10.1073/pnas.1720948115. Epub 2018 Apr 9.


Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy.

Peranzoni E, Bougherara H, Barrin S, Mansuet-Lupo A, Alifano M, Damotte D, Donnadieu E.

J Vis Exp. 2017 Dec 27;(130). doi: 10.3791/55709.


The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression.

Weiss JM, Guérin MV, Regnier F, Renault G, Galy-Fauroux I, Vimeux L, Feuillet V, Peranzoni E, Thoreau M, Trautmann A, Bercovici N.

Oncoimmunology. 2017 Jul 7;6(10):e1346765. doi: 10.1080/2162402X.2017.1346765. eCollection 2017.


Macrophages Induce Long-Term Trapping of γδ T Cells with Innate-like Properties within Secondary Lymphoid Organs in the Steady State.

Audemard-Verger A, Rivière M, Durand A, Peranzoni E, Guichard V, Hamon P, Bonilla N, Guilbert T, Boissonnas A, Auffray C, Eberl G, Lucas B, Martin B.

J Immunol. 2017 Sep 15;199(6):1998-2007. doi: 10.4049/jimmunol.1700430. Epub 2017 Aug 4.


Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration.

Bougherara H, Mansuet-Lupo A, Alifano M, Ngô C, Damotte D, Le Frère-Belda MA, Donnadieu E, Peranzoni E.

Front Immunol. 2015 Oct 12;6:500. doi: 10.3389/fimmu.2015.00500. eCollection 2015.


miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis.

Sonda N, Simonato F, Peranzoni E, Calì B, Bortoluzzi S, Bisognin A, Wang E, Marincola FM, Naldini L, Gentner B, Trautwein C, Sackett SD, Zanovello P, Molon B, Bronte V.

Immunity. 2013 Jun 27;38(6):1236-49. doi: 10.1016/j.immuni.2013.06.004.


Positive and negative influence of the matrix architecture on antitumor immune surveillance.

Peranzoni E, Rivas-Caicedo A, Bougherara H, Salmon H, Donnadieu E.

Cell Mol Life Sci. 2013 Dec;70(23):4431-48. doi: 10.1007/s00018-013-1339-8. Epub 2013 May 7. Review.


Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.

Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V.

Cell Rep. 2012 Sep 27;2(3):628-39. doi: 10.1016/j.celrep.2012.08.006. Epub 2012 Sep 6.


Myeloid cell diversification and complexity: an old concept with new turns in oncology.

Chioda M, Peranzoni E, Desantis G, Papalini F, Falisi E, Solito S, Mandruzzato S, Bronte V.

Cancer Metastasis Rev. 2011 Mar;30(1):27-43. doi: 10.1007/s10555-011-9268-1. Review. Erratum in: Cancer Metastasis Rev. 2011 Jun;30(2):271. Samantha, Solito [corrected to Solito, Samantha].


Measurement of myeloid cell immune suppressive activity.

Dolcetti L, Peranzoni E, Bronte V.

Curr Protoc Immunol. 2010 Nov;Chapter 14:Unit 14.17. doi: 10.1002/0471142735.im1417s91.


Myeloid-derived suppressor cell heterogeneity and subset definition.

Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V.

Curr Opin Immunol. 2010 Apr;22(2):238-44. doi: 10.1016/j.coi.2010.01.021. Epub 2010 Feb 17. Review.


Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, Grassi F, Bronte V.

Eur J Immunol. 2010 Jan;40(1):22-35. doi: 10.1002/eji.200939903.


Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.

Ugel S, Scarselli E, Iezzi M, Mennuni C, Pannellini T, Calvaruso F, Cipriani B, De Palma R, Ricci-Vitiani L, Peranzoni E, Musiani P, Zanovello P, Bronte V.

Blood. 2010 Feb 18;115(7):1374-84. doi: 10.1182/blood-2009-07-233270. Epub 2009 Nov 10.


Myeloid-derived suppressor cell role in tumor-related inflammation.

Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V.

Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Review.


Role of arginine metabolism in immunity and immunopathology.

Peranzoni E, Marigo I, Dolcetti L, Ugel S, Sonda N, Taschin E, Mantelli B, Bronte V, Zanovello P.

Immunobiology. 2007;212(9-10):795-812. Epub 2007 Nov 14. Review.


Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: a novel target for therapeutic intervention.

Bronte V, Cingarlini S, Marigo I, De Santo C, Gallina G, Dolcetti L, Ugel S, Peranzoni E, Mandruzzato S, Zanovello P.

Immunol Invest. 2006;35(3-4):327-57. Review.


Supplemental Content

Loading ...
Support Center